Philip Scheltens
Directeur VUmc Alzheimer Centrum

Presentatie prof. dr. Philip Scheltens

(Keynote spreker, presentatie in het Nederlands)

Professor Scheltens zal in zijn lezing stilstaan bij de omvang van het probleem dementie, de vele ziekten die eraan ten grondslag liggen en in het bijzonder de ziekte van Alzheimer. Van de laatste ziekte zal hij de vele aspecten belichten die deze ziekte zo bijzonder maken, zoals verschillen in presentatie, beloop en leeftijd van ontstaan. Tot slot geeft hij zijn visie op de mogelijkheden van therapie; waar staan we en waar gaan we heen.

Over prof. dr. Philip Scheltens

Prof. dr. Philip Scheltens is directeur van het VUmc Alzheimercentrum dat hij oprichtte in 2000. In 2011 werd hij tevens wetenschappelijk directeur van het Parelsnoer Instituut en benoemd tot lid van de Koninklijke Academie van Kunsten en Wetenschappen. Onder zijn leiding verschenen meer dan 50 proefschriften en hij heeft meer dan 665 publicaties op zijn naam staan. Hij is actief op velerlei terreinen en is de initiatiefnemer van het Deltaplan Dementie.

Biography dr Philip Scheltens

Department of Neurology, Alzheimer Center VU University Medical Center Amsterdam, The Netherlands

Dr Philip Scheltens studied at the VU University, Amsterdam, The Netherlands, gaining his MD in 1984, and PhD (Magnetic Resonance Imaging in Alzheimer’s disease) in 1993. Clinical residencies in neurosurgery at the Municipal Hospital Slotervaart, and at the VU (Vrije Universiteit) Medical Center, Amsterdam, supported his academic development.

Dr Scheltens is Professor of Cognitive Neurology and Director of the Alzheimer Center at the VU University Medical Center in Amsterdam, as well as Honorary Professor of Neurology at University College London. From 2011 onwards he is also scientific director of the Dutch Pearlstring Institute (PSI). In 2013 he was appointed vice-chair of the board of the Dutch “Deltaplan Dementie”. His main clinical and research interests are dementia in the broadest sense, from basic research to care and translational research. He is active in the field of biomarkers and clinical trials and has been the (inter) national PI for many studies, including Phase I–III multicentre clinical trials. He is founder of, and has directed since 2000, the VUmc Alzheimer Center, which during this time has produced over 50 PhD theses. He also founded the Alzheimer Research Center, a center dedicated to and specialised in Alzheimer clinical trials, of which he is now scientific adviser and member of the Board of Trustees.

Dr Scheltens is an active member of several societies, including the Dutch Society for Neurology, the AAN, the Alzheimer Imaging Consortium, the ISTAART Consortium, and the ECNP. He has been instrumental in organising several national and international conferences, including the Imaging Symposium attached to ICAD. He is past chair of the dementia panel of the EFNS. He was Associate Editor of the Journal of Neurology, Neurosurgery and Psychiatry until 2010. He was Chief Editor of the official journal of the Dutch Society of Neurology until November 2008.

He is co-editor-in-chief of Alzheimer’s Research & Therapy and acts as an ad hoc reviewer of scientific articles for all of the major journals. He has authored >665 peer reviewed papers and >50 book chapters. Dr Scheltens co-edited the books, Magnetic Resonance in Dementia (Springer), Neuroimaging in dementia (Springer) and Functional Magnetic Resonance Imaging: Clinical Applications(Oxford University Press). He was one of the founding fathers of, and has acted as Treasurer of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog), until 2011. He was elected member of the Royal Academy of Arts and Sciences in 2011 and act as secretary of the Medicine Section since 2012.

Recommended Articles